Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ·Healthcare·Biotechnology
$4.03
-1.95%
Mkt Cap $129.91M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $500.00K | — | — | -$0.08 | -$0.06 | +25.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.04 | $1.13 | +2925.00% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.04 | -$0.05 | -25.00% | — | — |
| Q2 2025 May 15, 2025 | — | $2.00M | — | -$0.03 | -$0.19 | -533.33% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.03 | $0.01 | +133.33% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.00 | -$0.48 | -9695.92% | — | — |
| Q3 2024 Aug 14, 2024 | $250.00K | — | — | $0.01 | $0.26 | +2500.00% | — | — |
| Q2 2024 May 9, 2024 | $500.00K | — | — | $0.02 | $0.04 | +100.00% | — | — |
| Q1 2024 Mar 6, 2024 | — | — | — | -$0.12 | -$0.08 | +33.33% | — | — |
| Q4 2023 Nov 9, 2023 | $600.00K | — | — | -$0.09 | -$0.08 | +11.11% | — | — |
| Q3 2023 Aug 10, 2023 | $700.00K | $674.00K | -3.71% | -$0.11 | -$0.03 | +72.73% | — | — |
| Q2 2023 May 11, 2023 | $688.67K | $666.00K | -3.29% | -$0.23 | -$0.08 | +65.22% | — | — |
| Q1 2023 Mar 6, 2023 | $711.00K | $681.00K | -4.22% | -$0.22 | -$0.22 | +0.00% | — | — |
| Q4 2022 Nov 10, 2022 | $700.00K | $682.00K | -2.57% | -$0.26 | -$0.18 | +30.77% | — | — |
| Q3 2022 Aug 10, 2022 | $700.00K | $674.00K | -3.71% | -$0.22 | -$0.27 | -22.73% | — | — |
| Q1 2022 Mar 30, 2022 | $692.50K | $666.00K | -3.83% | -$0.19 | -$0.27 | -41.85% | — | — |
| Q1 2022 Jan 11, 2022 | $700.00K | $674.00K | -3.71% | -$0.20 | -$0.22 | -10.00% | — | — |
| Q4 2021 Nov 24, 2021 | $912.80K | $683.00K | -25.18% | -$0.10 | -$0.21 | -110.00% | — | — |
| Q3 2021 Jul 14, 2021 | $970.00K | $681.00K | -29.79% | -$0.12 | -$0.17 | -41.67% | — | — |
| Q2 2021 Apr 13, 2021 | $665.00K | $665.00K | +0.00% | -$0.19 | -$0.17 | +10.53% | — | — |